CYTOTOXIC EFFECTS OF ETHYL ACETATE FRACTIONS FROM SECONDARY METABOLITES OF STREPTOMYCES SP. GMY01 ON HUMAN BREAST CANCER MCF7 CELL LINES
DOI:
https://doi.org/10.22159/ajpcr.2017v10s3.21351Keywords:
Streptomyces Sp GMY01, MCF7, cytotoxicity, MTTAbstract
Objective: This research aimed to fractionate the ethyl acetate extract from secondary metabolites of Streptomyces sp. GMY01 and to identify which fraction contains cytotoxic active compounds against human breast cancer MCF7 cell lines.
Methods: Secondary metabolites were obtained from fermentation of Streptomyces Sp. GMY01 for 15 d. The supernatant containing these secondary metabolites was extracted through partition using ethyl acetate as the solvent. Fractionation of the ethyl acetate extract was conducted via column chromatography using silica gel as the solid phase while the gradient mobile phase consisted of n-hexane, ethyl acetate, and methanol. The cytotoxicity of each fraction was calculated using MTT-assay.
Results: The ethyl acetate extract could be separated into 9 fractions using column chromatography. The cytotoxic effect of each fraction differed from each other. The smallest IC50 value was obtained from fraction 4. Further investigation should be conducted to discover the active anticancer compound. The active compound with cytotoxic effect was found in fraction 4 because of the highest IC50 value.
Conclusion: This fraction is potential to be investigated more deeply as anticancer, especially for breast cancer.Downloads
References
Balitbangkes. Basic Health Research. Indonesian Health Ministry: Jakarta; 2013.
WHO. Cancer; 2015: Available from: http://www.who.int/mediacentre/factsheets/fs297/en/. [Last accessed on 30 Mar 2016]
Bradner WT. Mitomycin C: a clinical update. Cancer Treatment Rev 2001;27:35-50.
Mao Y, Varoglu M, Sherman DH. Genetic localization and molecular characterization of two key genes (mit AB) required for biosynthesis of the antitumor antibiotic mitomycin C. J Bacteriol 1999;181:2199-208.
Farida Y. Combination methods for screening marine actinomycetes producing potential compounds as anticancer; Thesis, Gadjah Mada University; 2008.
Farida Y, Widada J, Meiyanto E. Combination methods for screening marine actinomycetes producing potential compounds as anticancer. Int J Biotechnol 2007;12:988-97.
Widowati EW. Toxic compounds in various actinomycetes GMY01 extracts against breast cancer cells T47D and MCF7, Thesis, Gadjah Mada University; 2010.
Sheeba JMDJ, Mohan CM, Marine H, Gauri D, Neeraj K, Mukund LA. Estrogen-regulated extracellular matrix remodeling genes in MCF-7 breast cancer cells. Gene Reports 2016;3:14–21.
Nugroho AE, Ikawati M, Hermawan A, Putri DDP, Meiyanto E. Cytotoxic effect of ethanolic extract fractions of Indonesia plant ficus septica burm. F. on human breast cancer T47D cell lines. Int J Phytomed 2011;3:216-26.
Smith JE. Biotechnology. Fifth edition. Cambridge University Press: New York; 2009.
Imaniar NI. Antiviral activity of secondary metabolites of the sea and land actinomycetes against dengue virus serotype-1, Thesis, Gadjah Mada University; 2013.
Supardan. Antiviral activity of secondary metabolites of actinomycetes against dengue virus serotype 3, Thesis, Gadjah Mada University; 2013.
Praditya DF. Potential antiviral activity of ethyl acetate extract and water extract of secondary metabolites of actinomycetes against dengue virus serotype 2 (DEN-2). Thesis, Gadjah Mada University; 2013.
Ghanbari K, Aghajani H, Golbabaee M, Khah EN, Nabavi SH, Koohian A. Column chromatography: a facile and inexpensive procedure to purify the red dopant DCJ applied for OLEDs. Adv Mater Phys Chem 2011;1:91-3.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
